why choose us

First received: February 10, 2023

Clinical Trial: Study of MRTX1133 in Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation

Study Status: Completed

Recruit Status: RECRUITING

Condition: Solid Tumor

Study Type: INTERVENTIONAL


Official Title: A Phase 1/2 Multiple Expansion Cohort Trial of MRTX1133 in Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation

Brief Summary: A Phase 1/2 study of MRTX1133 in solid tumors harboring a KRAS G12D mutation.

Read more